News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
Presentation AHA 2018 REDUCE-IT Trial: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial Presenter: Deepak L Bhatt November 16, 2018
News Conference News AHA 2018 Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis Caitlin E. Cox November 13, 2018
News Conference News AHA 2018 Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs Yael L. Maxwell November 12, 2018
Presentation AHA 2018 PIONEER Trial: Angiotensin Receptor-NeprilysinInhibition in Patients Hospitalized With Acute Decompensated Heart Failure Presenter: Eric J Velazquez November 12, 2018
News Conference News AHA 2018 Remission, Not Cure: No Weaning Off Meds for Dilated Cardiomyopathy Patients, Says TRED-HF Shelley Wood November 11, 2018
News Conference News AHA 2018 PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure Michael O'Riordan November 11, 2018
News Conference News AHA 2018 DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors Todd Neale November 10, 2018
News Conference News AHA 2018 AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City Shelley Wood November 05, 2018
News Daily News Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS Michael O'Riordan October 03, 2018
News Daily News AHA Scientific Statement Aims to Raise Awareness of Chagas Disease and Risk for Cardiomyopathy Lucy Hicks August 24, 2018
News Daily News Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes Michael O'Riordan August 09, 2018
News Daily News Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations Todd Neale June 04, 2018
News Daily News Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows Michael O'Riordan April 05, 2018
News Daily News Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway Michael O'Riordan January 02, 2018